Sonoma Pharmaceuticals, Inc. (SNOA)

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Pharmaceuticals	14.29M	12.74M	13.27M	12.63M	18.63M
Pharmaceuticals Growth	12.19%	-4.05%	5.10%	-32.21%	3.91%
Total	14.29M	12.74M	13.27M	12.63M	18.63M
Total Growth	12.19%	-4.05%	5.10%	-32.21%	3.91%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
United States	2.61M	3.06M	3.43M	3.81M	5.42M
United States Growth	-14.62%	-10.79%	-9.96%	-29.75%	-32.19%
Europe	5.52M	4.78M	4.05M	3.41M	-
Europe Growth	15.52%	18.02%	18.80%	-	-
Asia	2.32M	2.30M	2.45M	2.35M	-
Asia Growth	0.83%	-6.24%	4.30%	-	-
Latin America	2.96M	1.73M	2.38M	2.10M	5.98M
Latin America Growth	71.61%	-27.57%	13.75%	-64.94%	58.39%
Rest of The World	875.00K	872.00K	959.00K	966.00K	-
Rest of The World Growth	0.34%	-9.07%	-0.72%	-	-
Europe and Rest of The World	-	-	-	-	7.23M
Europe and Rest of The World Growth	-	-	-	-	17.36%
Total	14.29M	12.74M	13.27M	12.63M	18.63M
Total Growth	12.19%	-4.05%	5.10%	-32.21%	3.91%

Source: S&P Global Market Intelligence.